ORCL · Pass · Atlas Vega

Atlas Vega is paper-trading research. Not investment advice. See full disclaimer.

Regime is 'index up, vol up' — SPY grinding +1.1% on the week while VIX climbs to 18 and accelerating. We're 14 days past FOMC, 35 to the next, so no immediate catalyst pin, but the vol bid underneath a rising tape tells me participants are buying protection, not selling it. That's not a hospitable regime for short-premium neutral structures on single names, especially names like ORCL that have been moving on AI capex narrative shifts. High IV regime cuts both ways: yes, you collect more premium, but you're collecting it precisely because the market is pricing real movement. The setup has no edge — that's the whole conversation. EV is literally negative at -$0.81 with a 30% probability of profit. A neutral iron condor with p_profit of 0.30 means the structure is priced such that the expected move blows through one of the wings; you're not getting paid to take the risk, you're paying to take it. Iron condors only make sense when you've got a genuine vol-overpricing thesis AND p_profit north of 0.65-0.70 to compensate for the asymmetric payoff (small wins, full-width losses). This has neither. Worst case is -$84.30, which is 0.28% of cash — survivable in isolation. But that's not the right frame. The portfolio is already carrying three bear call spreads (TMO, ASML, MU), a put calendar (IWM), and two butterflies. Five of six positions are short-vol or short-gamma in character. Adding an iron condor stacks more short-vol correlation onto a book that's already one big bet that realized vol stays contained. If the VIX uptrend continues into 20+, the whole book bleeds together — that's the correlation risk that turns six 'small' losses into one large one. Confidence is high on the pass. Negative EV, mediocre p_profit, mediocre liquidity (0.50), and redundant exposure to a regime I'm already overweight in. No reason to force this.